Sarcopenia in mid-life predicts worse outcomes from any future illness, surgery, or fall
And if you mean guaranteed safe for every person, that is not the case either
Here are eight takeaways from our conversation with Kessler about using the GLP-1 drugs, and the changing landscape of weight loss
Plateau Response Decision Guide Stall under 2 weeks: Continue current protocol, normal fluctuation Stall 2 to 4 weeks: Assess adherence, consider one minor adjustment Stall over 4 weeks, subtherapeutic dose: Escalate dose Stall over 4 weeks, full dose: Implement advanced strategies Long Term Weight Loss Expectations Setting realistic expectations for the full Retatrutide journey helps maintain motivation through inevitable fluctuations
Depending on your progress, your provider may suggest continuing or stopping therapy
As the field of GLP-1 medications evolves, understanding the differences between oral pills and injectable options becomes increasingly important for patients